文献速递脑血管病

远程卒中项目改善综合医疗系统21家医院的急性卒中溶栓治疗

Novel Telestroke Program Improves Thrombolysis for Acute Stroke Across 21 Hospitals of an Integrated Healthcare System.
PubMed 文献 · Stroke · 2017-12-15

本研究评估了Kaiser Permanente北加州在21家卒中中心实施标准化改良赫尔辛基方案和远程卒中神经科医生管理的效果。结果显示,实施后阿替普酶给药量从每月34例增至62例,中位门-针时间从53.5分钟降至34分钟,且症状性颅内出血率无显著差异。

要点

  • 标准化远程卒中方案使门-针时间中位数从53.5分钟降至34分钟。
  • 阿替普酶月给药量从34例增至62例,症状性颅内出血率无显著增加。
  • 门-针时间<60分钟的比例从61.0%提升至87.1%。

核心结论

  • 在21家医院实施标准化改良赫尔辛基方案联合远程卒中管理,与阿替普酶给药增加、门-针时间显著缩短及不良结局未增加相关。

研究设计与样本

  • 研究为前后对照设计,比较实施前9个月与实施后相应9个月日历期间各中心的数据。
  • 共纳入实施前310例和實施后557例接受阿替普酶治疗的急性缺血性卒中患者。

主要发现

  • 实施后阿替普酶给药量从基线每月34例增至每月62例(P<0.001)。
  • 中位门-针时间从实施前53.5分钟降至实施后34分钟(P<0.001)。
  • 门-针时间<60分钟的患者比例从61.0%升至87.1%(P<0.001)。
  • 门-针时间<30分钟的比例在实施后为40.8%,实施前为4.2%。
  • 症状性颅内出血率两期无显著差异(3.8% vs 2.2%,P=0.29)。

临床怎么用

  • 在综合医疗系统中推广标准化远程卒中方案可能缩短门-针时间并提高溶栓率。
  • 远程卒中神经科医生管理所有急诊卒中病例或可作为改善急性卒中救治的模式。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Faster treatment with intravenous alteplase in acute ischemic stroke is associated with better outcomes. Starting in 2015, Kaiser Permanente Northern California redesigned its acute stroke workflow across all 21 Kaiser Permanente Northern California stroke centers to (1) follow a single standardized version of a modified Helsinki model and (2) have all emergency stroke cases managed by a dedicated telestroke neurologist. We examined the effect of Kaiser Permanente Northern California's Stroke EXpediting the PRrocess of Evaluating and Stopping Stroke program on door-to-needle (DTN) time, alteplase use, and symptomatic intracranial hemorrhage rates. METHODS: The program was introduced in a staggered fashion from September 2015 to January 2016. We compared DTN times for a seasonally adjusted 9-month period at each center before implementation to the corresponding 9-month calendar period from the start of implementation. The primary outcome was the DTN time for alteplase administration. Secondary outcomes included rate of alteplase administrations per month, symptomatic intracranial hemorrhage, and disposition at time of discharge. RESULTS: This study included 310 patients treated with alteplase in the pre-EXpediting the PRrocess of Evaluating and Stopping Stroke period and 557 patients treated with alteplase in the EXpediting the PRrocess of Evaluating and Stopping Stroke period. After implementation, alteplase administrations increased to 62/mo from 34/mo at baseline (P<0.001). Median DTN time decreased to 34 minutes after implementation from 53.5 minutes prior (P<0.001), and DTN time of <60 minutes was achieved in 87.1% versus 61.0% (P<0.001) of patients. DTN times <30 minutes were much more common in the Stroke EXpediting the PRrocess of Evaluating and Stopping Stroke period (40.8% versus 4.2% before implementation). There was no significant difference in symptomatic intracranial hemorrhage rates in the 2 periods (3.8% versus 2.2% before implementation; P=0.29). CONCLUSIONS: Introduction of a standardized modified Helsinki protocol across 21 hospitals using telestroke management was associated with increased alteplase administrations, significantly shorter DTN times, and no increase in adverse outcomes.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Nguyen-Huynh MN, Klingman JG, Avins AL, et al. Novel Telestroke Program Improves Thrombolysis for Acute Stroke Across 21 Hospitals of an Integrated Healthcare System. Stroke. 2017. PMID: 29247142. doi:10.1161/STROKEAHA.117.018413

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。